18 October 2018
We are pleased to report that Accreditation certificate of foreign animal drug manufacturer for Friulchem S.p.A. was issued on 12 October 2018.
This certificate is an important milestone for our company and represents a serious commitment to continuous improvement as we proceed along our path.
20 September 2018
5 September 2018
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 45,000 visiting pharma professionals over three days.
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is an effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Friulchem S.p.A. will be exhibiting at CPhI Worldwide in Madrid from October 9-11, booth 4K32.
We would welcome the opportunity to meet to learn about your business and discuss ways we may be able collaborate to advance your developments and manufacturing goals.
16 July 2018
Friulia sostiene il consolidamento finanziario di Friulchem, azienda specializzata nella trasformazione di principi attivi per la produzione di farmaci e medicinali generici in ambito umano e veterinario per conto terzi. Con un intervento di private equity del valore di 1,9 milioni di Euro, Friulia consentirà l’incremento del giro d’affari della realtà di Vivaro, grazie agli investimenti in R&D per lo sviluppo di nuovi prodotti e per l’ampiamento della linea di produzione previsti dal piano industriale 2017-20.
Per leggere l'articolo completo apparso sul Friuli: http://www.ilfriuli.it/articolo/Economia/Friulia_investe_nello_sviluppo_di_Friulchem/4/183492
12 June 2018
In the next forthcoming CPhI China, you will be able to discover more on Evultis products and the new Joint Venture. The new collaboration in China allows Evultis to be up to date on the market situation, and propose the best solutions for its partners.
30 March 2018
CPhI Japan is the opportunity to meet the country's industry leaders.This event has been the central platform for international businesses for over ten years, where decision makers from Japan and overseas connect and do business.
Friulchem will attend this important event. Meet us at stand IP-14.
15 February 2018
Chinese New Year, also known as the Spring Festival in modern China, often called the Lunar New Year in Asia, is an important Chinese festival celebrated at the turn of the traditional lunisolar Chinese calendar.
24 January 2018
Friulchem will attend to CPhI Japan 2018.
CPhI Japan is Japan’s most comprehensive pharma event, which brings together more than 20,000 pharma industry professionals from 55+ countries. A wide range of exhibitors from all pharma areas active in Japan as well as free to attend seminars presented by governmental bodies and other important institutions is what you can find. Hosting exhibitors from ingredients, contract services and biopharma through to technology, packaging and machinery.
Register now for free.
16 January 2018
The group Evultis SA – Friulchem S.p.A. started a new collaboration in China that allows it to be up to date on the market situation and to be able to satisfy customers requests promptly.
This way the group will be faster in providing the information to the partners.
11 January 2018
DCAT Value Chain Insights published a new article on Patent Ruling for Rifaximin.
Mexican Institute of Industrial Property (IMPI), the patent and trademark administration body of Mexico, recently dismissed a patent-infringement and unfair competition case filed against Interquim, S.A. de C.V.
23 November 2017
Friulchem S.p.A. has filed FC-Cubes patents in EU, US, BRASIL, AUSTRALIA, and MX. The idea started from it is not easy to administer oral medicines to pets. Many owners try to hide tablets in a piece of meat or cheese to give it to their cat or dog. While for the horses they have to deal mainly with products in powder or paste forms. It rarely works: the animal eats the treat and neglects the tablet. Tablets usually produced by extrusion.
Friulchem identified a different manufacturing method, which allows reaching a chewable matrix with all the benefits presented for the drugs already on the market, but without the limits connected to production by extrusion.
Friulchem technology is based on a compression stage, which shows different advantages compared to extrusion:
- Compression provides full control over the weight of the chewable cube and hence over the quantity of API contained in each unit of the finished product, thereby guaranteeing compliance with treatment;
- By compression the outcome could be obtained in different shapes, from the typical square to new “suggestions” heart, bones, fish-shape).
Additionally, FC-Cubes could be manufactured with higher fat and palatable material content, which leads to perfect appetency (total ingestion by animals even on a repeat basis). The compositions of the matrix developed in Friulchem is high palatable and able to mask also active components which are particularly disliked by the animals.
6 November 2017
Friulchem S.p.A. is the beneficiary of contribution from Tender POR FESR 2014-2020. Activity 2.3.a.1 “Assistance in support of technological investments of small and medium-size enterprises (SMI)” – Tender DGR 1898 of 07/10/2016 for project titled TECHNOLOGICAL INNOVATION FOR THE ANALYSIS LABORATORY, financially supported by the European Union, the Republic of Italy and the Autonomous Region of Friuli Venezia Giulia.
The project entails the purchase of two pieces of equipment to be installed in the analysis laboratory. Such devices are needed to carry out analyses on substances or substance compounds. The investment also concerns the purchase of two PCs each to be connected to each device.
Project’s main objectives:
- 10% increase in the laboratory’s production capacity (increase of number of samples to be analyzed within a certain amount of time);
- Increase of the analysis laboratory’s competitiveness, thanks to the availability of a faster and more advanced service;
- Increase of the overall competitiveness of the company within the market.
The project was approved with an admissible cost of € 108,189.60 and we were awarded a financial contribution of € 41,562.28.
Friulchem S.p.A. è beneficiaria di un contributo a valere sul Bando POR FESR 2014-2020. Attività 2.3.a.1 “Aiuti agli investimenti tecnologici delle PMI” – Bando DGR 1898 del 07/10/2016 con un progetto dal titolo INNOVAZIONE TECNOLOGICA PER IL LABORATORIO DI ANALISI, con il supporto finanziario da parte dell’Unione Europea, dalla Repubblica Italiana e dalla Regione Autonoma Friuli Venezia Giulia.
Il progetto prevede l’acquisto di due apparecchiature specifiche da inserire nel laboratorio di analisi. Tali apparecchiature sono necessarie per la realizzazione di analisi sulle sostanze o su miscele di sostanze. L’investimento riguarda anche l’acquisto di due PC da collegare a ciascuna apparecchiatura.
Obiettivi principali del progetto:
- Incremento della capacità produttiva del laboratorio (incremento del numero di campioni analizzabili per unità di tempo) del 10%;
- Incremento della competitività del laboratorio di analisi offrendo un servizio più avanzato e veloce;
- Incremento della competitività complessiva dell’impresa all’interno del mercato.
Il progetto è stato approvato con una spesa ammessa di € 108.189,60 e ci è stato concesso un contributo di € 41.562,28.
20 October 2017
Friulchem S.p.A is installing a new micronization unit at its facility in Vivaro, Italy.
This new installation in the Vivaro plant will allow Friulchem to increase its micronization capacity by 1.8 times current capacity (from 250 kg/day up to 700 kg/day), and it will be operational this autumn.
FC Micronization Technology ensures the products’ particle size homogeneity and stability because it works under highly pure nitrogen flow, thus safeguarding products during the micronization process.
Contact email@example.com for more information.
14 September 2017
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt.
Contact firstname.lastname@example.org and meet our team at CPhI Worldwide 2017 to discover our news on human, cosmetic & veterinary divisions.
5 August 2017
DCAT Week 2018 is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT) to assist its member companies with their business development objectives.
23 March 2017
The pet industry in the US and many other countries is booming.
According to the American Pet Product Association (APPA), Americans spent approximately $58 billion on pet products and services in 2014.